Entrada Therapeutics Stock Price History

If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 19.83, as last reported on the 29th of November, with the highest price reaching 19.93 and the lowest price hitting 19.30 during the day. Entrada Therapeutics appears to be not too volatile, given 3 months investment horizon. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which denotes the company had a 0.15% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Entrada Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Entrada Therapeutics' Mean Deviation of 2.37, coefficient of variation of 1049.26, and Downside Deviation of 3.16 to check if our risk estimates are consistent with your expectations. At present, Entrada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 13.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.84, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1452

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns		TRDA
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return